Could less immunosuppression after liver transplant be safer?
NCT ID NCT05238155
First seen Mar 31, 2026 · Last updated May 11, 2026 · Updated 7 times
Summary
This study looked at whether giving liver transplant patients fewer immune-suppressing drugs could lower their risk of a serious complication called graft-versus-host disease (GVHD), where donor cells attack the recipient's body. About 100 adults who received a liver or combined liver-kidney transplant took part. Researchers tracked how many developed GVHD or experienced organ rejection within one year after transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT VS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
Conditions
Explore the condition pages connected to this study.